People: Amedisys Inc (AMED.O)

AMED.O on Nasdaq

20.30USD
3:58pm EDT
Price Change (% chg)

$-0.30 (-1.46%)
Prev Close
$20.60
Open
$20.72
Day's High
$20.84
Day's Low
$19.90
Volume
255,402
Avg. Vol
493,620
52-wk High
$22.58
52-wk Low
$12.60

Search Stocks

Summary

Name Age Since Current Position

Donald Washburn

69 2014 Non-Executive Chairman of the Board

Ronald LaBorde

57 2014 President, Interim Chief Executive Officer, Director

Dale Redman

66 2014 Interim Chief Financial Officer

Jeffrey Jeter

42 2004 Chief Compliance Officer

David Bucey

56 2009 General Counsel, Corporate Secretary

Michael Fleming

63 2009 Chief Medical Officer

Nathaniel Zilkha

38 2014 Director

Linda Hall

65 2013 Independent Director

Jake Netterville

76 1997 Independent Director

Peter Ricchiuti

57 1997 Independent Director

David Castille

2013 IR Contact Officer, Director, Treasury/Finance

Biographies

Name Description

Donald Washburn

Mr. Donald A. Washburn is Non-Executive Chairman of the Board of the Company. He a private investor for over five years, currently serves as a director on the boards of the following publicly traded companies: (i) LaSalle Hotel Properties, a real estate investment trust; (ii) The Greenbrier Companies, Inc., a manufacturer and lessor of rail cars and barges; and (iii) Key Technology, Inc., which designs and manufactures process automation systems for the food processing and industrial markets. He also serves on multiple private company boards. He also is a retired Executive Vice President of Northwest Airlines, Inc. and was the Chairman and President-Northwest Cargo, Inc. Prior to joining Northwest Airlines, Inc., Mr. Washburn was a corporate Senior Vice President of Marriott Corporation, most recently Executive Vice President and general manager of its Courtyard Hotel division.

Ronald LaBorde

Mr. Ronald A. LaBorde is President, Interim Chief Executive Officer, Director of Amedisys Inc. He is no longer Chief Financial Officer of the Company, effective March 24, 2014. Mr. LaBorde is company's President (since November 2011) and Chief Financial Officer (since January 2012) and is a member of Board of Directors. He served as company's Lead Director from February 2003 until his employment with the Company in November 2011. Previously, from July 2008 to November 2011, Mr. LaBorde was the principal executive officer of HR Solutions, LLC, a private company that provides outsourced administration associated with human resources, most recently as its Chief Executive Officer (from September 2010 until November 2011) and as its President (from July 2008 to August 2010). Prior to July 2008, Mr. LaBorde managed personal investments, which included non-public operating companies, and provided management consulting services to various privately-held companies, including HR Solutions, LLC. From 1995 to May 2003, Mr. LaBorde was President and Chief Executive Officer of Piccadilly Cafeterias, Inc., a publicly traded retail restaurant business.

Dale Redman

Mr. Dale E. Redman has been appointed as Interim Chief Financial Officer of Amedisys Inc, effective March 24, 2014. Mr. Redman previously served as the Company’s Chief Financial Officer from February 2007 through December 2011 and retired from the Company as its Executive Vice President of Finance in February 2012. Prior to February 2007, Mr. Redman served as Managing Director at Windward Capital Consulting, LLC, where he assisted businesses with capital structure issues and provided management consulting services in support of such companies’ growth strategies. Prior to April 1999, he was the Executive Vice President and Chief Financial Officer of United Companies Financial Corporation, which was a publicly-traded home mortgage and home equity lender based in Baton Rouge, Louisiana. He graduated from Louisiana State University with a Masters Degree in Accounting.

Jeffrey Jeter

Mr. Jeffrey D. Jeter serves as Chief Compliance Officer of Amedisys Inc., since March 2004. From April 2001 to March 2004, he served as Company's Vice President of Compliance/Corporate Counsel. Prior to joining the Company, he served as an Assistant Attorney General for the Louisiana Department of Justice beginning in 1996, where he prosecuted health care fraud and nursing home abuse.

David Bucey

Mr. David R. Bucey serves as General Counsel, Corporate Secretary of Amedisys Inc. He joined Company in June 2008 as General Counsel and Corporate Secretary and was appointed an executive officer in October 2009. Prior to joining Amedisys, Mr. Bucey served as in-house counsel with The Coca-Cola Company in Atlanta, Georgia beginning in 1994, most recently in the positions of Senior Counsel of Mergers and Acquisitions and Senior Counsel of Transactions and Securities. Prior to his tenure at The Coca-Cola Company, he was a partner in Long, Aldridge & Norman, a Atlanta law firm (now McKenna, Long & Aldridge).

Michael Fleming

Dr. Michael O. Fleming, M.D., serves as Chief Medical Officer of Amedisys Inc. He joined Company in September 2009 as Chief Medical Officer and was appointed an executive officer in October 2009. Dr. Fleming began his medical career in private practice in the late 1970’s with a focus on family medicine. He retired from private practice in 2006, most recently in the position of founder and Managing Partner of Family Practice Associates of Shreveport (d/b/a The Family Doctors). Prior to joining our company in 2009, he provided consulting services to multiple organizations, including Amedisys. He has a Board Certification from the American Board of Family Medicine and has held multiple leadership positions with the American Academy of Family Physicians. He is also currently the Chairman of the Medical Care Advisory Counsel to the Secretary of the Louisiana Department of Health and Hospitals and President of the Louisiana Healthcare Quality Forum.

Nathaniel Zilkha

Mr. Nathaniel M. Zilkha is Director of Amedisys Inc. He is a Member of the general partner of KKR & Co. L.P. ( together with its affiliates, “KKR”) and serves as Head of KKR’s credit platform and as its Global Co-Head of Special Situations. Mr. Zilkha joined KKR in 2007. As Head of Credit, he works closely with the credit portfolio teams to help drive investment performance, strategy, business development and coordination across the platform. He is a member of the Leveraged Credit, Private Credit and Special Situations Investment Committees as well as the KKR Asset Management Portfolio Management Committee. He also spent time as a member of the Healthcare Private Equity Team in KKR’s Menlo Park office. Prior to joining KKR, Mr. Zilkha was a member of the Principal Investment Area of Goldman, Sachs & Co., where he invested in private equity and principal debt transactions. He is currently on the Boards of Directors of Amedisys, Inc., the Winoa Group and QMH Limited. He was formerly on the Boards of Directors of Harden Healthcare, Oriental Brewery and Jazz Pharmaceuticals. Mr. Zilkha graduated cum laude from Princeton University.

Linda Hall

Ms. Linda J. Hall is appointed as an Independent Director of Amedisys, Inc. She is the Entrepreneur-in-Residence at the Carlson School of Business at the University of Minnesota. Previously, Ms. Hall served as the Chief Executive Officer of MinuteClinic (which was sold to CVS Pharmacy in 2006), the Chief Executive Officer of Accurate Home Care (a home healthcare company serving chronically ill pediatric patients) and as an interim executive at UnitedHealth Group, leading their corporate social responsibility initiative for AARP. In addition, Ms. Hall’s past management experience includes serving as President of Ceridian Performance Partners and Vice President of Honeywell’s Worldwide Consumer Business Group. Ms. Hall’s past public sector board experience includes membership on the board of the 9th District Federal Reserve Bank, serving as its Chair for the last two years of her term. Ms. Hall has substantial public company board experience. She currently serves on the board of directors of Investors Real Estate Trust, a diversified real estate investment trust which includes healthcare investments. Previously, she served on the boards of Health Fitness Corporation, August Technology and MTS Systems Corporation. She is also a member of the boards of directors of Ascension Health Ventures (strategic healthcare venture fund), BodyMedia (fitness/health telemonitoring), Laastari/R Clinic. Ltd. (telemedicine and retail health clinics—Sweden and Finland) and PreciouStatus (interface monitoring technology for daycare and hospitals). Ms. Hall is Chair of the Compliance and Ethics Committee of the Board of Directors.

Jake Netterville

Mr. Jake L. Netterville serves as an Independent Director of Amedisys Inc., since 1997. Mr. Netterville was the Managing Partner of Postlethwaite & Netterville, a professional accounting corporation, from 1977 to 1998 and has since been Chairman of its Board of Directors. Mr. Netterville is a certified public accountant, has served as Chairman of the Board of Directors of the American Institute of Certified Public Accountants, Inc. (“AICPA”) and is a permanent member of the AICPA’s Governing Council. Mr. Netterville was appointed Chairman of the Audit Committee of Board of Directors in February 2003.

Peter Ricchiuti

Mr. Peter F. Ricchiuti serves as an Independent Director of Amedisys Inc. Mr. Ricchiuti has been Assistant Dean and Director of Research of BURKENROAD REPORTS at Tulane University’s A. B. Freeman School of Business since 1993, and a Clinical Professor of Finance at Tulane since 1986. Mr. Ricchiuti is Chairman of the Quality of Care Committee of Board of Directors.

David Castille

Basic Compensation

Name Fiscal Year Total

Donald Washburn

--

Ronald LaBorde

1,382,170

Dale Redman

1,080,090

Jeffrey Jeter

421,453

David Bucey

443,907

Michael Fleming

493,739

Nathaniel Zilkha

--

Linda Hall

--

Jake Netterville

--

Peter Ricchiuti

--

David Castille

--
As Of 30 Dec 2013

Options Compensation

Search Stocks